These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23894239)

  • 21. Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins.
    Oh HM; Park JH; Song DH; Chung ME
    Toxins (Basel); 2015 Dec; 8(1):. PubMed ID: 26712786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
    Simonetta Moreau M; Cauhepe C; Magues JP; Senard JM
    Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans.
    Eleopra R; Tugnoli V; De Grandis D
    Mov Disord; 1997 Jan; 12(1):89-94. PubMed ID: 8990059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals.
    Mukai Y; Shimatani Y; Sako W; Asanuma K; Nodera H; Sakamoto T; Izumi Y; Kohda T; Kozaki S; Kaji R
    Toxicon; 2014 Apr; 81():32-6. PubMed ID: 24495439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of multiuse botulinum toxin vials for intralaryngeal injection.
    Barrow EM; Rosen CA; Hapner ER; Smith S; Hatcher JL; Simpson B; Johns MM
    Laryngoscope; 2015 May; 125(5):1149-54. PubMed ID: 25476036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
    Sloop RR; Cole D; Patel MC
    Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial neurophysiological studies of intramuscular botulinum-A toxin in humans.
    Hamjian JA; Walker FO
    Muscle Nerve; 1994 Dec; 17(12):1385-92. PubMed ID: 7969239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of surface EMG signals to monitor the effect of a Botox treatment in six healthy ponies and two horses with stringhalt: preliminary study.
    Wijnberg ID; Schrama SE; Elgersma AE; Maree JT; de Cocq P; Back W
    Equine Vet J; 2009 Mar; 41(3):313-8. PubMed ID: 19469243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone loss after temporarily induced muscle paralysis by Botox is not fully recovered after 12 weeks.
    Grimston SK; Silva MJ; Civitelli R
    Ann N Y Acad Sci; 2007 Nov; 1116():444-60. PubMed ID: 17584988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Botox and Neuronox on muscle force generation in mice.
    Stone AV; Ma J; Whitlock PW; Koman LA; Smith TL; Smith BP; Callahan MF
    J Orthop Res; 2007 Dec; 25(12):1658-64. PubMed ID: 17600825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthetical treatment for facial paralysis using static and dynamic techniques].
    Wang H; Li S; Yang M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Dec; 20(12):1189-92. PubMed ID: 17228677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1.
    Sampaio C; Ferreira JJ; Simões F; Rosas MJ; Magalhães M; Correia AP; Bastos-Lima A; Martins R; Castro-Caldas A
    Mov Disord; 1997 Nov; 12(6):1013-8. PubMed ID: 9399229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensor digitorum brevis and extensor hallusis brevis transplantation for treatment of long-standing facial paralysis.
    Huang WQ; Fang BR; Fang XQ; Wang CJ
    Chin J Traumatol; 2009 Feb; 12(1):3-9. PubMed ID: 19159508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum A toxins: units versus units.
    Wohlfarth K; Göschel H; Frevert J; Dengler R; Bigalke H
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):335-40. PubMed ID: 9089663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability study on quantitative detection of extensor digitorum brevis strength with needle electromyography and nerve conduction.
    Gao D; Xia Q; Ran D; Tian D; Zhu GY; Fan LH
    Fa Yi Xue Za Zhi; 2013 Dec; 29(6):409-13. PubMed ID: 24665609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis.
    Kim HS; Hwang JH; Jeong ST; Lee YT; Lee PK; Suh YL; Shim JS
    Dev Med Child Neurol; 2003 Mar; 45(3):200-6. PubMed ID: 12613778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology of botulinum neurotoxin type A].
    Bigalke H
    Wien Klin Wochenschr; 2001; 113 Suppl 4():2-5. PubMed ID: 15506044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative Injection of Botulinum Toxin A into Orbicularis Oculi Muscle for the Treatment of Crow's Feet.
    Guerrissi JO
    Plast Reconstr Surg; 2000 May; 104(6):2219-2225. PubMed ID: 11242328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.